Guillain-Barré Syndrome After COVID-19 Infection in Korea: A Case Series.
Nayoung RyooHyoshin SonJean Hee KimDae Woong BaeJae Young AnPublished in: Journal of Korean medical science (2024)
Guillain-Barré syndrome (GBS) is an autoimmune-driven condition characterized by acute polyneuropathy, often emerging as a sequel to prior infections or vaccinations. This study presents the first reported cases of GBS emerging after the full recovery from coronavirus disease 2019 (COVID-19) infection in Korea. Despite experiencing mild acute COVID-19 symptoms, these patients faced substantial weakness attributed to GBS, significantly affecting their daily lives. The timely administration of intravenous immunoglobulin treatment halted the progression of symptoms, underscoring the critical importance of early intervention. These cases highlight the potential for neurological complications associated with COVID-19 and underscore the necessity for continuous monitoring and timely medical care.
Keyphrases
- coronavirus disease
- liver failure
- sars cov
- end stage renal disease
- respiratory failure
- respiratory syndrome coronavirus
- drug induced
- ejection fraction
- randomized controlled trial
- chronic kidney disease
- newly diagnosed
- case report
- multiple sclerosis
- prognostic factors
- high dose
- aortic dissection
- hepatitis b virus
- sleep quality
- intensive care unit
- low dose
- blood brain barrier
- mechanical ventilation